Drug Information
      Drug (ID: DG00598) and It's Reported Resistant Information
  
  
        Type(s) of Resistant Mechanism of This Drug
    
    
      Drug Resistance Data Categorized by Their Corresponding Diseases
    
   
    ICD-02: Benign/in-situ/malignant neoplasm
        
      | Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|  | ||||
| Key Molecule: hsa-mir-155 | [1] | |||
| Molecule Alteration | Expression | Up-regulation | ||
| Resistant Disease | Mycosis fungoides [ICD-11: 2B01.0] | |||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | MyLa cells | Embryo | Homo sapiens (Human) | N.A. | 
| MJ cells | Peripheral blood | Homo sapiens (Human) | CVCL_1414 | |
| In Vivo Model | SCID nude mouse xenograft model | Mus musculus | ||
| Experiment for Molecule Alteration | qRT-PCR | |||
| Experiment for Drug Resistance | Flow cytometry assay | |||
| Mechanism Description | Oncogenic miR-155 appears to contribute to the cancerous phenotype of MyLa and MJ cells. | |||
| Key Molecule: hsa-mir-155 | [1] | |||
| Molecule Alteration | Expression | Up-regulation | ||
| Resistant Disease | Mycosis fungoides [ICD-11: 2B01.0] | |||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | MyLa cells | Embryo | Homo sapiens (Human) | N.A. | 
| MJ cells | Peripheral blood | Homo sapiens (Human) | CVCL_1414 | |
| In Vivo Model | SCID nude mouse xenograft model | Mus musculus | ||
| Experiment for Molecule Alteration | qRT-PCR | |||
| Experiment for Drug Resistance | Flow cytometry assay | |||
| Mechanism Description | Oncogenic miR-155 appears to contribute to the cancerous phenotype of MyLa and MJ cells. | |||
      References
  
  visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
